Vernon Thompson, Jr. v. Janssen Pharmaceuticals, Inc.
This text of Vernon Thompson, Jr. v. Janssen Pharmaceuticals, Inc. (Vernon Thompson, Jr. v. Janssen Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS MAR 8 2019 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT
VERNON A. THOMPSON, JR. and No. 17-56769 FLORIA M. GRIFFIN, D.C. No. Plaintiffs-Appellants, 2:16-cv-02628-PSG-AGR
v. MEMORANDUM* JANSSEN PHARMACEUTICALS, INC. a/k/a ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC., and JOHNSON & JOHNSON, INC.
Defendants-Appellees.
Appeal from the United States District Court for the Central District of California Phillip S. Gutierrez, District Judge, Presiding
Submitted March 5, 2019** Pasadena, California
Before: FERNANDEZ and OWENS, Circuit Judges, and DONATO,*** District Judge.
* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). *** The Honorable James Donato, United States District Judge for the Northern District of California, sitting by designation. Plaintiffs Vernon A. Thompson, Jr. and his mother, Floria M. Griffin,
(together, “Thompson”) appeal from the district court’s order denying their motion
for voluntary dismissal under Federal Rule of Civil Procedure 41(a)(2). The
district court also granted summary judgment in favor of defendants Janssen
Pharmaceuticals, Inc. and Johnson & Johnson (together, “Janssen”), but Thompson
does not appeal the summary judgment order. We have jurisdiction pursuant to 28
U.S.C. § 1291. We affirm.
We have “long held that the decision to grant a voluntary dismissal under
Rule 41(a)(2) is addressed to the sound discretion of the District Court, and its
order will not be reversed unless the District Court has abused its discretion.”
Hamilton v. Firestone Tire & Rubber Co., 679 F.2d 143, 145 (9th Cir. 1982).
When ruling on a motion for voluntary dismissal without prejudice, the district
court “must determine whether the defendant will suffer some plain legal prejudice
as a result of the dismissal.” Westlands Water Dist. v. United States, 100 F.3d 94,
96 (9th Cir. 1996) (citations omitted). Legal prejudice is “prejudice to some legal
interest, some legal claim, [or] some legal argument.” Id. at 97. A district court
may consider whether the plaintiff has asked for a voluntary dismissal to avoid a
likely adverse ruling. Terrovona v. Kincheloe, 852 F.2d 424, 429 (9th Cir. 1988).
Here, the district court considered permissible factors in evaluating prejudice
and denying the Rule 41(a)(2) motion. The district court found that granting the
2 motion might require Janssen to face litigation on this claim in state court although
it had already engaged in substantial discovery and reached the summary judgment
stage in federal court. The district court noted that Thompson had offered no
expert disclosures or expert reports to support his product liability claims against
Janssen, and filed the Rule 41(a)(2) motion only after becoming aware that Janssen
would seek summary judgment. The district court also found that Thompson had
not adequately explained why he delayed so long in requesting a voluntary
dismissal to refile in a similar state court proceeding that he had known about for
many months. Because the district court’s determinations were not based on an
erroneous view of the law or a clearly erroneous assessment of the facts, it did not
abuse its discretion.
AFFIRMED.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
Vernon Thompson, Jr. v. Janssen Pharmaceuticals, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/vernon-thompson-jr-v-janssen-pharmaceuticals-inc-ca9-2019.